Vol 79, No 12 (2021)
Short communication
Published online: 2021-12-02
Direct oral anticoagulants in patients with atrial fibrillation following bariatric surgery: A single center experience
Abstract
Not available
References
- Panchal G, Mahmood M, Lip GYH. Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2. Kardiol Pol. 2019; 77(5): 515–524.
- Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42(5): 373–498.
- Ministrini S, Mondovecchio G, Lupattelli G. New insights in pathophysiology of cardiovascular benefits after obesity surgery. Kardiol Pol. 2020; 78(7-8): 657–658.
- Spaniolas K, Kasten KR, Brinkley J, et al. The changing bariatric surgery landscape in the USA. Obes Surg. 2015; 25(8): 1544–1546.
- Steffel J, Collins R, Antz M, et al. External reviewers. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace. 2021; 23(10): 1612–1676.
- Martin KA, Lee CR, Farrell TM, et al. Oral anticoagulant use after bariatric surgery: a literature review and clinical guidance. Am J Med. 2017; 130(5): 517–524.
- DeCamillo D, Haymart B, Barnes GD. Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series. J Thromb Thrombolysis. 2021 [Epub ahead of print].
- Hendricks AK, Zieminski JJ, Yao X, et al. Safety and efficacy of oral anticoagulants for atrial fibrillation in patients after bariatric surgery. Am J Cardiol. 2020; 136: 76–80.
- Janion-Sadowska A, Sadowski M, Konieczyńska M, et al. Polish regional differences in patient knowledge on atrial fibrillation and its management as well as in patterns of oral anticoagulant prescription. Kardiol Pol. 2019; 77(4): 437–444.
- Azar AJ, Cannegieter SC, Deckers JW, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993; 69(3): 236–239.
- Undas A, Drabik L, Potpara T, et al. Bleeding in anticoagulated patients with atrial fibrillation: practical considerations. Pol Arch Intern Med. 2020; 130(1): 47–58.
- Self TH, Oliphant CS, Reaves AB, et al. Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms. Thromb Res. 2015; 135(1): 5–8.
- Pignatelli P, Violi F, Pastori D. Integrated care management of patients with atrial fibrillation-far from optimal. Pol Arch Intern Med. 2020; 130(3): 176–178.
- Rottenstreich A, Barkai A, Arad A, et al. The effect of bariatric surgery on direct-acting oral anticoagulant drug levels. Thromb Res. 2018; 163: 190–195.
